LabMD litigation against FTC lingers
Although the Federal Trade Commission won its effort to quash a lawsuit over its probe of LabMD, the now-defunct medical laboratory is still trying to sue three agency employees.
The pushback on convenience, resort and junk fees
Unexpected, surreptitious fees in retail transactions — additions like “convenience fees” and “resort fees” — have proliferated wildly over the past 30 years. When they aren’t clearly disclosed at the start of a transaction, their omission can deceive consumers and distort the purchase decision....
Current Issue: 979
Debate swells over vitality of DOJ’s leniency program
Antitrust officials at the Justice Department have boasted for decades about the crucial role the leniency program plays in enforcement efforts, but lately a debate is stirring over its effectiveness.
Chopra defends use of dissents, outlines role on commission
Federal Trade Commission member Rohit Chopra isn’t afraid of disagreeing with his colleagues. He’s made that fairly clear with his numerous dissents since taking office in May 2018. In a recent...
Big spring conferences fall victim to concerns over coronavirus
The biggest conferences for privacy and antitrust won’t be held this spring because of concerns over the coronavirus pandemic.
Hoffman jumps to Cleary Gottlieb, reflects on FTC stint
Bruce Hoffman chuckled as he described his decision to sign on as a partner in the Washington, DC, office of Cleary Gottlieb.
With ‘detox’ tea case, FTC puts influencers like Cardi B on notice
The Federal Trade Commission says its settlement with a company for making unsupportive health claims about a “detox” tea broke new ground, but the agency is under fire for not doing more.
DOJ’s enforcement record mixed from Carter administration to present
President Jimmy Carter tackled several antitrust issues during his administration, but like other parts of his agenda, it was difficult to pigeonhole his actions ideologically.